Zentalis Pharmaceuticals, Inc. (ZNTL)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
5. 11
+0.54
+11.8162%
$
339.56M Market Cap
- P/E Ratio
- Div Yield
3.55M Volume
-3.66 Eps
$ 4.57
Previous Close 
Want to track ZNTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Zentalis Pharmaceuticals, Inc. (ZNTL) Statistics
Valuation metrics
Market Cap 339.56M
Enterprise value 370.48M
Trailing P/E (ttm) -2.95
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) -
Price/Book (mrq) 1.97
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.55M
Average volume (90 days) 1.4M
Price summary
52-Week low 1.21
52-Week high 6.95
Beta -
50-Day moving average 4.13
200-Day moving average 3.2
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.49%
Return on equity -0.54%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.21
Current ratio (mrq) 6.19%
Book value per share (mrq) 2.6
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
